OCS
Oculis Holding AG

84
Mkt Cap
$1.12B
Volume
49,469.00
52W High
$23.08
52W Low
$14.00
PE Ratio
-7.65
OCS Fundamentals
Price
$19.34
Prev Close
$19.28
Open
$19.27
50D MA
$19.32
Beta
0.85
Avg. Volume
101,097.70
EPS (Annual)
-$2.41
P/B
6.15
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Research Analysts Issue Forecasts for Oculis FY2025 Earnings
Oculis Holding AG (NASDAQ:OCS - Free Report) - Research analysts at Chardan Capital lifted their FY2025 earnings per share (EPS) estimates for Oculis in a report released on Tuesday, November 11th...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
FY2025 EPS Estimates for Oculis Lifted by Leerink Partnrs
Oculis Holding AG (NASDAQ:OCS - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings estimates for Oculis in a research note issued to investors on Tuesday, November...
MarketBeat·5d ago
News Placeholder
Bank of America Issues Pessimistic Forecast for Oculis (NASDAQ:OCS) Stock Price
Bank of America dropped their target price on Oculis from $30.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday...
MarketBeat·6d ago
News Placeholder
HC Wainwright Has Strong Estimate for Oculis FY2025 Earnings
Oculis Holding AG (NASDAQ:OCS - Free Report) - HC Wainwright increased their FY2025 earnings estimates for shares of Oculis in a report released on Tuesday, November 11th. HC Wainwright analyst Y...
MarketBeat·6d ago
News Placeholder
Oculis (NASDAQ:OCS) Sees Strong Trading Volume on Analyst Upgrade
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume on Analyst Upgrade...
MarketBeat·8d ago
News Placeholder
Oculis (NASDAQ:OCS) Receives "Buy" Rating from Needham & Company LLC
Needham & Company LLC reaffirmed a "buy" rating and set a $36.00 target price on shares of Oculis in a report on Tuesday...
MarketBeat·8d ago
News Placeholder
Oculis (NASDAQ:OCS) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS
Oculis (NASDAQ:OCS - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.40) earnings per share for the quarter, beating analysts' consensus estimates of...
MarketBeat·9d ago
News Placeholder
Oculis Holding AG (OCS) Reports Q3 Loss, Beats Revenue Estimates
Oculis Holding AG (OCS) delivered earnings and revenue surprises of +20.00% and +23.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Vericel Corporation (VCEL) Q3 Earnings and Revenues Top Estimates
Vericel (VCEL) delivered earnings and revenue surprises of +600.00% and +5.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Harmony Biosciences (HRMY) Moves 12.7% Higher: Will This Strength Last?
Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·27d ago

Latest OCS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.